Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment

Cancer Immunology Research

Volumn 3, Issue 1, 2015, Pages 85-95

  Danelli, Luca ^a,b   Frossi, Barbara ^a   Gri, Giorgia ^a   Mion, Francesca ^a   Guarnotta, Carla ^c   Bongiovanni, Lucia ^c   Tripodo, Claudio ^c   Mariuzzi, Laura ^a   Marzinotto, Stefania ^a   Rigoni, Alice ^d   Blank, Ulrich ^b   Colombo, Mario P ^d   Pucillo, Carlo E ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^c UNIVERSITY OF PALERMO   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN E; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; CD40 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; SPLEEN CELL; SUPPRESSOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; CELL COMMUNICATION; COLONIC NEOPLASMS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; CELL COMMUNICATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID CELLS; NITRIC OXIDE; TUMOR MICROENVIRONMENT;

EID: 84930091454     PISSN: 23266066     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0102     Document Type: Article

References (44)

1. Colotta F, Allavena P, Sica A., Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81.
2. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-74.
3. Gabrilovich DI, Bronte V, Chen S.H., Colombo MP, Ochoa A, Ostrand Rosenberg S, et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007;67:425-5.
4. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, et al. Identification of discrete tumor-induced myeloidderived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111:4233-44.
5. Youn J-I, Nagaraj S., Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181:5791-802.
6. Ostrand-Rosenberg S. Myeloid-derived suppressor cells: moremechanisms for inhibiting antitumor immunity. Cancer Immunol Immunother 2010;59:1593-600.
7. Frossi B, De Carli M, Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J Leukoc Biol 2004; 75:579-85.
8. Rao KN, Brown MA Mast cells. Ann N Y Acad Sci 2008;1143:83-104.
9. Maltby S, Khazaie K, McNagny KM Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 2009;1796:19-26.
10. Pittoni P, Tripodo C, Piconese S., Mauri G, Parenza M, Rigoni A., et al. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence ofhighly malignant neuroendocrine cancers. Cancer Res 2011;71:5987-97.
11. Wei J-J, Song C-W, Sun L-C, Yuan Y, Li D., Yan B, et al. SCF and TLR4 ligand cooperateto augmentthe tumor-promoting potentialofmast cells. Cancer Immunol Immunother 2012;61:303-12.
12. Huang B, Lei Z, Zhang G-M, Li D, Song C., Li B, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008;112: 1269-79.
13. Yang Z, Zhang B, Li D., Lv M, Huang C, Shen G-X, et al. Mast cells mobilize myeloid-derived suppressor cells and treg cells in tumor microenvironment via IL-17pathwayinmurine hepatocarcinoma model. In: Bereswill S, editor. PLoS ONE 2010;5:e8922.
14. Cheon EC, Khazaie K, Khan M.W., Strouch MJ, Krantz SB, Phillips J, et al Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APC 468 mice. Cancer Res 2011;71:1627-36.
15. Saleem SJ, Martin RK, Morales J.K., Sturgill JL, Gibb DR, Graham L, et al Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol 2012;189:511-5.
16. Morales JK, Saleem SJ, Martin R.K., Saunders BL, Barnstein BO, Faber TW, et al Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol 2014;95:643-50.
17. Gri G, Piconese S, Frossi B., Manfroi V, Merluzzi S, Tripodo C., et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008;29: 771-81.
18. Peddareddigari VG, Wang D, DuBois RN The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 2010;3:149-66.
19. Ugel S, Peranzoni E, Desantis G., Chioda M, Walter S, Weinschenk T., et al. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep 2012;2:628-39.
20. Melillo RM, Guarino V, Avilla E, Galdiero MR, Liotti F, Prevete N, et al. Mast cells have a protumorigenic role in human thyroid cancer. Oncogene 2010;29:6203-15.
21. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499-506.
22. Gallina G, Dolcetti L, Serafini P., Santo CD, Marigo I, Colombo MP, et al Tumors induce a subset of inflammatory monocytes with immunosup pressive activity on CD8+ T cells. J Clin Invest 2006;116:2777-90.
23. Haverkamp JM, Crist SA, Elzey B.D., Cimen C, Ratliff TL. In vivo suppressive functionofmyeloid-derived suppressor cells islimited tothe inflammatory site. Eur J Immunol 2011;41:749-59.
24. Nakae S, Suto H, Kakurai M., Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci U S A 2005;102:6467-72.
25. Hochdörfer T., Kuhny M, Zorn C.N., Hendriks RW, Vanhaesebroeck B, Bohnacker T, et al Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal 2011;23:866-75.
26. Greifenberg V, Ribechini E, Rößbner S, Lutz MB. Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur J Immunol 2009;39:2865-76.
27. Bunt SK, Clements VK, Hanson E.M., Sinha P., Ostrand-Rosenberg S. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J Leukoc Biol 2009;85:996-1004.
28. Klemm S, Gutermuth J, Hültner L, Sparwasser T., Behrendt H, Peschel C, et al The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J Exp Med 2006;203:337-47.
29. Corzo CA, Cotter MJ, Cheng P, Cheng F., Kusmartsev S, Sotomayor E, et al Mechanism regulating reactive oxygen species in tumor-induced myeloidderived suppressor cells. J Immunol 2009;182:5693-701.
30. Kay JE. Mechanisms of T lymphocyte activation. Immunol Lett 1991; 29:51-4.
31. Sade-Feldman M., Kanterman J, Ish-Shalom E, Elnekave M., Horwitz E, Baniyash M. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013;38:541-54.
32. Zhao X, Rong L, Zhao X., Li X, Liu X, Deng J., et al. TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest 2012;122: 4094-104.
33. Hu X, Li B, Li X., Zhao X, Wan L, Lin G., et al. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. J Immunol 2014;192:1320-31.
34. Pan PY, Ma G, Weber K.J., Ozao-Choy J, Wang G, Yin B., et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 2010;70:99-108.
35. Merluzzi S, Frossi B, Gri G., Parusso S, Tripodo C, Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood 2010;115:2810-7.
36. Liu J, Zhang Y, Zhao J., Yang Z, Li D, Katirai F., et al. Mast cell: insight into remodeling a tumor microenvironment. Cancer Metastasis Rev 2011;30: 177-84.
37. Martin RK, Saleem SJ, Folgosa L, Zellner H.B., Damle SR, Nguyen GKT, et al. Mast cell histamine promotes the immunoregulatory activity of myeloidderived suppressor cells. J Leukoc Biol 2014;96:151-9.
38. Youn J-I, Kumar V., Collazo M, Nefedova Y, Condamine T., Cheng P, et al. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 2013;14:211-20.
39. Dunn GP, Bruce AT, Ikeda H, Old L.J., Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8.
40. Hosoi A, Matsushita H, Shimizu K., Fujii S-I, Ueha S, Abe J., et al. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosup pressive mechanism via recruitment of myeloid-derived suppressor cells. Int J Cancer 2014;134:1810-22.
41. McGray AJR, Hallett R, Bernard D., Swift S, Zhu Z, Teoderascu F., et al. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Ther 2014;22:206-18.
42. Nagaraj S, Gupta K, Pisarev V., Kinarsky L, Sherman S, Kang L., et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007;13:828-35.
43. Huang B, Lei Z, Zhao J., Gong W, Liu J, Chen Z., et al. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 2007;252:86-92.
44. Jackson AR, Hegde VL, Nagarkatti P.S., Nagarkatti M. Characterization of endocannabinoid-mediatedinductionofmyeloid-derived suppressor cells involving mast cells and MCP-1. J Leukoc Biol 2014;95:609-19.